- Home
- VTGN
as 07-26-2024 4:00pm EST
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.
| Founded: | 1998 | Country: | United States |
| Employees: | N/A | City: | SOUTH SAN FRANCISCO |
| Market Cap: | 96.5M | IPO Year: | N/A |
| Target Price: | $19.00 | AVG Volume (30 days): | 100.4K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.52 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.63 - $24.71 | Next Earning Date: | 08-08-2024 |
| Revenue: | $1,064,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | -71.48% | Revenue Growth (next year): | -11.49% |
Latest VistaGen Therapeutics Inc. News
VTGN Breaking Stock News: Dive into VTGN Ticker-Specific Updates for Smart Investing
Pharmaceutical Technology
17 days ago
Vistagen secures new patents for PH80 migraine treatment
Business Wire
18 days ago
Vistagen Broadens PH80 Global Intellectual Property Portfolio with New Patents for the Treatment of Migraine
Business Wire
a month ago
Vistagen Awarded Mental Health America’s Platinum Bell Seal for Workplace Mental Health for the Second Consecutive Year
Simply Wall St.
a month ago
Vistagen Therapeutics Full Year 2024 Earnings: EPS Beats Expectations
Insider Monkey
a month ago
VistaGen Therapeutics, Inc. (NASDAQ:VTGN) Q4 2024 Earnings Call Transcript
Business Wire
a month ago
Vistagen Reports Fiscal Year 2024 Financial Results and Provides Corporate Update
Business Wire
2 months ago
Vistagen to Report Fiscal Year 2024 Financial Results and Host Corporate Update Conference Call on June 11, 2024
Business Wire
2 months ago
Vistagen to Present at the Jefferies Global Healthcare Conference
Compare VTGN vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VTGN VistaGen Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.